NRIX

NRIX

USD

Nurix Therapeutics Inc. Common stock

$12.260-0.040 (-0.325%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$12.300

Haut

$12.530

Bas

$12.160

Volume

1.16M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.2B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.24M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $8.18Actuel $12.260Haut $29.56

Actualités Connexes

Analyst Upgrades

Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target

Needham analyst Gil Blum reiterates Nurix Therapeutics with a Buy and maintains $26 price target.

Voir plus
Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target

BTIG analyst Jeet Mukherjee reiterates Nurix Therapeutics with a Buy and maintains $27 price target.

Voir plus
BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target
GlobeNewswire

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

Voir plus
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

Voir plus
Nurix Therapeutics to Participate in Upcoming Investor Conferences

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.